CYP2A13
MOLECULAR TARGETcytochrome P450 family 2 subfamily A member 13
CYP2A13 (cytochrome P450 family 2 subfamily A member 13) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CYP2A13
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Methoxsalen | 1.10 | 2 |
| 2 | Pilocarpine | 1.10 | 2 |
About CYP2A13 as a Drug Target
CYP2A13 (cytochrome P450 family 2 subfamily A member 13) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented CYP2A13 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CYP2A13 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.